INCYTE CORPORATION Capital Expenditures Incurred but Not yet Paid
INCYTE CORPORATION (INCY) reported Capital Expenditures Incurred but Not yet Paid of $1.63 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-04-28
- INCYTE CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $1.63M, a 43.49% decline year-over-year.
- INCYTE CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $771.00K.
- INCYTE CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $112.00K, a 95.91% decline year-over-year.
- INCYTE CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $1.16M, a 177.22% increase year-over-year.
- INCYTE CORPORATION capital expenditures incurred but not yet paid for fiscal 2025 was $4.93M, a 89.80% increase from fiscal 2024.
- INCYTE CORPORATION capital expenditures incurred but not yet paid for fiscal 2024 was $2.60M, a 48.59% decline from fiscal 2023.
- INCYTE CORPORATION capital expenditures incurred but not yet paid for fiscal 2023 was $5.05M, a 44.63% increase from fiscal 2022.
- INCYTE CORPORATION capital expenditures incurred but not yet paid for fiscal 2022 was $3.49M, a 87.11% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.63M 10-Q · filed 2026-04-28 | $2.40M derived: sum of 2 quarters · filed 2026-04-28 | $2.52M derived: sum of 3 quarters · filed 2026-04-28 | $3.67M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $771.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $883.00K derived: sum of 2 quarters · filed 2026-02-10 | $2.04M derived: sum of 3 quarters · filed 2026-02-10 | $4.93M 10-K · filed 2026-02-10 |
| 2025-09-30 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.27M derived: sum of 2 quarters · filed 2025-10-28 | $4.16M 10-Q · filed 2025-10-28 | $3.22M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $4.05M 10-Q · filed 2025-07-29 | $3.10M derived: sum of 3 quarters · filed 2026-04-28 | $5.84M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $2.89M 10-Q · filed 2026-04-28 | $1.95M derived: sum of 2 quarters · filed 2026-04-28 | $4.69M derived: sum of 3 quarters · filed 2026-04-28 | $5.10M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | -$941.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.80M derived: sum of 2 quarters · filed 2026-02-10 | $2.21M derived: sum of 3 quarters · filed 2026-02-10 | $2.60M 10-K · filed 2026-02-10 |
| 2024-09-30 | $2.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $3.15M derived: sum of 2 quarters · filed 2025-10-28 | $3.54M 10-Q · filed 2025-10-28 | $8.58M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $417.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $800.00K 10-Q · filed 2025-07-29 | $5.84M derived: sum of 3 quarters · filed 2026-02-10 | $1.43M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $383.00K 10-Q · filed 2025-04-29 | $5.42M derived: sum of 2 quarters · filed 2026-02-10 | $1.01M derived: sum of 3 quarters · filed 2026-02-10 | $2.38M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $632.00K derived: sum of 2 quarters · filed 2026-02-10 | $1.99M derived: sum of 3 quarters · filed 2026-02-10 | $5.05M 10-K · filed 2026-02-10 |
| 2023-09-30 | -$4.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$3.05M derived: sum of 2 quarters · filed 2024-10-29 | $11.00K 10-Q · filed 2024-10-29 | -$5.33M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $4.42M 10-Q · filed 2024-07-30 | -$923.00K derived: sum of 3 quarters · filed 2025-02-10 | -$1.04M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $3.06M 10-Q · filed 2024-04-30 | -$2.28M derived: sum of 2 quarters · filed 2025-02-10 | -$2.40M derived: sum of 3 quarters · filed 2025-02-10 | -$9.21M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | -$5.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | -$5.46M derived: sum of 2 quarters · filed 2025-02-10 | -$12.27M derived: sum of 3 quarters · filed 2025-02-10 | $3.49M 10-K · filed 2025-02-10 |
| 2022-09-30 | -$116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | -$6.93M derived: sum of 2 quarters · filed 2023-10-31 | $8.84M 10-Q · filed 2023-10-31 | $12.04M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | -$6.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $8.95M 10-Q · filed 2023-08-01 | $12.16M derived: sum of 3 quarters · filed 2024-02-13 | $5.23M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $15.76M 10-Q · filed 2023-05-02 | $18.97M derived: sum of 2 quarters · filed 2024-02-13 | $12.04M derived: sum of 3 quarters · filed 2024-02-13 | $21.60M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$3.73M derived: sum of 2 quarters · filed 2024-02-13 | $5.84M derived: sum of 3 quarters · filed 2024-02-13 | $27.10M 10-K · filed 2024-02-13 |
| 2021-09-30 | -$6.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $2.63M derived: sum of 2 quarters · filed 2022-11-01 | $23.89M 10-Q · filed 2022-11-01 | $33.86M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $9.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $30.82M 10-Q · filed 2022-08-02 | $40.79M derived: sum of 3 quarters · filed 2023-02-07 | $38.81M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $21.26M 10-Q · filed 2022-05-03 | $31.23M derived: sum of 2 quarters · filed 2023-02-07 | $29.25M derived: sum of 3 quarters · filed 2023-02-07 | $30.49M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $9.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $7.99M derived: sum of 2 quarters · filed 2023-02-07 | $9.22M derived: sum of 3 quarters · filed 2023-02-07 | $22.81M 10-K · filed 2023-02-07 |
| 2020-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$746.00K derived: sum of 2 quarters · filed 2021-11-02 | $12.84M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $14.82M 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | $13.58M 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | $12.73M 10-K · filed 2022-02-08 | |||
| 2019-03-31 | $8.41M 10-Q · filed 2020-05-05 | |||
| 2018-12-31 | $7.67M 10-K · filed 2021-02-09 | |||
| 2017-12-31 | -$5.13M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$5.22M derived: sum of 2 quarters · filed 2020-02-13 | -$3.50M derived: sum of 3 quarters · filed 2020-02-13 | $5.64M 10-K · filed 2020-02-13 |
| 2017-09-30 | -$92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $1.64M derived: sum of 2 quarters · filed 2018-10-30 | $10.77M 10-Q · filed 2018-10-30 | $14.77M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $10.87M 10-Q · filed 2018-07-31 | $14.87M derived: sum of 3 quarters · filed 2019-02-14 | $15.29M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $9.14M 10-Q · filed 2018-05-01 | $13.14M derived: sum of 2 quarters · filed 2019-02-14 | $13.56M derived: sum of 3 quarters · filed 2019-02-14 | |
| 2016-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $4.42M derived: sum of 2 quarters · filed 2019-02-14 | $10.99M 10-K · filed 2019-02-14 | |
| 2016-09-30 | $419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $6.99M 10-Q · filed 2017-10-31 | ||
| 2016-06-30 | $6.57M 10-Q · filed 2017-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |